International Journal of Maternal and Child Health & AIDS - IJMA

International Journal of Maternal and Child Health & AIDS - IJMA Peer-reviewed, open-access, global health journal covering maternal and child health and HIV/AIDS issues around the world.

IJMA focuses on the social determinants of health and disease as well as on the disparities in the burden of communicable and non-communicable diseases affecting infants, children, women, adults, and families in developing countries. IJMA focuses primarily on MCH and HIV/AIDS issues in developing countries. High-quality papers, opinion articles, and commentaries from scientists, researchers, and experts working with developing country populations in non-LMICs will also be considered.

Innovative Maternal Health Solutions for PPH in South SudanA comprehensive postpartum hemorrhage (PPH) intervention pack...
11/30/2024

Innovative Maternal Health Solutions for PPH in South Sudan

A comprehensive postpartum hemorrhage (PPH) intervention package was successfully implemented in six maternity facilities across South Sudan. This initiative integrated heat-stable carbetocin (HSC) for PPH prevention and tranexamic acid (TXA) for treatment, addressing challenges in cold-chain dependency and resource limitations.

The stepwise approach showed significant results: HSC replaced oxytocin as the primary uterotonic for PPH prevention, and TXA became a standard for treatment. Providers gained skills through hands-on training and collaborative platforms, improving PPH detection and management. This model highlights the feasibility of scaling similar interventions in low-resource humanitarian settings.

👉 Learn how innovative solutions are transforming maternal health in fragile settings. Read the full study here: https://mchandaids.org/management-of-postpartum-hemorrhage-in-humanitarian-settings-using-heat-stable-carbetocin-and-tranexamic-acid/

Advancing Maternal Health in India with Heat-Stable CarbetocinThe introduction of heat-stable carbetocin (HSC) in public...
11/30/2024

Advancing Maternal Health in India with Heat-Stable Carbetocin

The introduction of heat-stable carbetocin (HSC) in public health facilities in Madhya Pradesh through a public-private partnership demonstrated its feasibility for preventing postpartum hemorrhage (PPH). This innovative approach addressed challenges like oxytocin's cold chain dependency, ensuring safe and effective PPH prevention.

Across 15 health facilities, nearly universal use of uterotonics was observed, with HSC administered in over 96% of cases. The initiative highlighted significant knowledge improvements among providers and better adherence to active management of the third stage of labor (AMTSL). The project shows promise for scaling HSC adoption across India to reduce maternal mortality.

👉 Learn more about this impactful initiative transforming maternal health care. Read the full details here: https://mchandaids.org/introduction-of-heat-stable-carbetocin-through-a-public-private-partnership-model-in-india-a-retrospective-study-to-determine-feasibility-and-its-optimal-use-in-public-health-settings/

Empowering Midwives in Fragile Settings with Advanced PPH TrainingMidwives in humanitarian contexts are at the forefront...
11/30/2024

Empowering Midwives in Fragile Settings with Advanced PPH Training

Midwives in humanitarian contexts are at the forefront of maternal health, often managing postpartum hemorrhage (PPH) with limited resources. A new training model, incorporating heat-stable carbetocin (HSC) and tranexamic acid (TXA), has improved provider knowledge, skills, and confidence in PPH prevention and treatment.

This approach uses a low-dose, high-frequency (LDHF) strategy, combining webinars, in-person workshops, and hands-on skill drills. Participants reported significant knowledge gains and practical improvements, emphasizing midwifery leadership, teamwork, and quality care. Action plans and WhatsApp-based communities further strengthened collaboration and sustainability.

👉 Learn how this innovative training model is transforming maternal care in humanitarian settings. Read the full details here: https://mchandaids.org/empowering-midwives-in-humanitarian-settings-integrating-heat-stable-carbetocin-and-tranexamic-acid-into-postpartum-hemorrhage-training/

Innovative Solutions for Maternal Health in Resource-Limited SettingsHeat-stable carbetocin (HSC) has emerged as a relia...
11/30/2024

Innovative Solutions for Maternal Health in Resource-Limited Settings

Heat-stable carbetocin (HSC) has emerged as a reliable solution for preventing postpartum hemorrhage (PPH) in humanitarian contexts, favored by healthcare providers for its efficacy and lack of cold-chain requirements. Tranexamic acid (TXA) has also proven effective for PPH treatment, though its application remains limited by fewer cases requiring its use.

Addressing challenges like medication confusion and insufficient record-keeping, initiatives such as WhatsApp-based communities and hands-on training have strengthened provider collaboration and skills. These measures are paving the way for improved maternal health outcomes in resource-limited and fragile settings.

👉 Discover how HSC and TXA are transforming maternal care in challenging environments. Read the full details here: https://mchandaids.org/postpartum-hemorrhage-in-humanitarian-settings-implementation-insights-from-using-heat-stable-carbetocin-and-tranexamic-acid/

Improving PPH Care in Uganda’s Humanitarian Settings with Heat-Stable Carbetocin and Tranexamic AcidPostpartum hemorrhag...
11/30/2024

Improving PPH Care in Uganda’s Humanitarian Settings with Heat-Stable Carbetocin and Tranexamic Acid

Postpartum hemorrhage (PPH) is a critical concern in humanitarian settings, often compounded by unreliable cold-chain systems. A study in Uganda explored a phased implementation of heat-stable carbetocin (HSC) and tranexamic acid (TXA) in six health facilities. This innovative approach included training, collaborative platforms, and visual aids for care protocols.

HSC became the primary uterotonic in later phases, reducing reliance on oxytocin, while TXA was moderately adopted for PPH treatment. The results demonstrate the feasibility of integrating these interventions in fragile contexts, emphasizing the need for continuous capacity building and supportive supervision.

👉 Learn how HSC and TXA are enhancing maternal care in humanitarian settings. Read the full study here: https://mchandaids.org/postpartum-hemorrhage-in-humanitarian-settings-heat-stable-carbetocin-and-tranexamic-acid-implementation-study-in-uganda/

Transforming Maternal Health with Heat-Stable Carbetocin in NigeriaIn Nigeria, postpartum hemorrhage (PPH) is a leading ...
11/28/2024

Transforming Maternal Health with Heat-Stable Carbetocin in Nigeria

In Nigeria, postpartum hemorrhage (PPH) is a leading cause of maternal deaths often exacerbated by the suboptimal quality of uterotonics like oxytocin and misoprostol. A study across three states introduced heat-stable carbetocin (HSC), a uterotonic that remains effective without refrigeration, as a safer and more reliable alternative for PPH prevention.

HSC was used in 56% of deliveries, with healthcare providers reporting high acceptance due to its efficacy, ease of administration, and reduced side effects. Structured training, mentoring, and improved supply chain management were key enablers for the successful adoption of HSC in these facilities.

👉 Learn more about how HSC is transforming maternal health in Nigeria. Read the full study here: https://mchandaids.org/an-implementation-research-study-on-uterotonics-use-patterns-and-heat-stable-carbetocin-acceptability-and-safety-for-prevention-of-postpartum-hemorrhage-in-nigeria/

Heat-Stable Carbetocin Enhances Maternal Health Care in KenyaIn Kenya, postpartum hemorrhage (PPH) remains a leading cau...
11/28/2024

Heat-Stable Carbetocin Enhances Maternal Health Care in Kenya

In Kenya, postpartum hemorrhage (PPH) remains a leading cause of maternal deaths, with unreliable cold chain systems hindering the use of oxytocin for prevention. The introduction of heat-stable carbetocin (HSC) in 39 public sector hospitals across 10 counties has demonstrated its feasibility and acceptability in overcoming these challenges.

The initiative involved training healthcare providers, improving PPH protocols, and enhancing awareness of HSC’s benefits, including its ease of use and storage without refrigeration. Policymakers supported its adoption, highlighting its potential to address cold chain issues and improve PPH prevention in resource-limited settings.

👉 Learn more about how HSC is transforming maternal health in Kenya. Read the full study here: https://mchandaids.org/introduction-of-heat-stable-carbetocin-for-postpartum-hemorrhage-prevention-in-public-sector-hospitals-in-kenya-provider-experience-and-policy-insights/

Improving Maternal Health with Life-Saving Medicines in Sub-Saharan AfricaA pilot program in five Sub-Saharan African co...
11/28/2024

Improving Maternal Health with Life-Saving Medicines in Sub-Saharan Africa

A pilot program in five Sub-Saharan African countries successfully introduced heat-stable carbetocin (HSC) for postpartum hemorrhage (PPH) prevention and tranexamic acid (TXA) for treatment. Both medicines were safely and effectively used in routine care, offering a practical solution to reducing maternal mortality in the region.

Heat-stable solutions like HSC, combined with structured training and improved access, can address the challenges of cold chain dependency and medicine shortages, advancing maternal health outcomes.

Learn how innovative interventions are transforming PPH care in Sub-Saharan Africa. Read the full study here: https://mchandaids.org/integrating-heat-stable-carbetocin-and-tranexamic-acid-for-prevention-and-management-of-postpartum-hemorrhage-in-sub-saharan-africa-a-five-country-pilot-implementation-study/

End-to-End Solutions for Improving Access to Life-Saving Maternal Health MedicinesLow- and middle-income countries (LMIC...
11/28/2024

End-to-End Solutions for Improving Access to Life-Saving Maternal Health Medicines

Low- and middle-income countries (LMICs) face a disproportionate burden of maternal deaths, with postpartum hemorrhage (PPH) as the leading cause. Despite the proven effectiveness of heat-stable carbetocin (HSC) and tranexamic acid (TXA) in PPH prevention and treatment, systemic and regulatory challenges hinder their widespread use. A recent study emphasizes the importance of structured end-to-end (E2E) strategies to bridge gaps in access and ensure these life-saving interventions reach those who need them most.

👉 Learn how innovative approaches are transforming maternal health in LMICs. Read the full research collection here: https://mchandaids.org/a-tale-of-two-medicines-the-need-for-ownership-end-to-end-planning-and-execution-for-development-and-introduction-of-maternal-health-medicines/

Closing the Gap in Maternal Health: Transforming Postpartum Hemorrhage Care in Low- and Middle-Income CountriesPostpartu...
11/28/2024

Closing the Gap in Maternal Health: Transforming Postpartum Hemorrhage Care in Low- and Middle-Income Countries

Postpartum hemorrhage (PPH) remains a leading cause of maternal deaths, particularly in low- and middle-income countries (LMICs). A recent research collection explores the potential of heat-stable carbetocin (HSC) and tranexamic acid (TXA) to address this critical issue. These WHO-recommended medicines are effective in reducing PPH-related complications, even in challenging healthcare settings with limited cold storage infrastructure.

Studies conducted across nine LMICs demonstrate:
Safety and Feasibility: High acceptance and usability by healthcare providers.
Scalability: Potential for integration into public health systems to improve maternal outcomes.
Impact: Paving the way for reducing maternal mortality and achieving Sustainable Development Goals.

👉 Learn how these innovative approaches are revolutionizing maternal health care. Read the full research collection here: https://mchandaids.org/feasibility-acceptability-and-appropriate-use-of-novel-and-lesser-used-medicines-for-prevention-and-treatment-of-postpartum-hemorrhage-evidence-from-implementation-research/

Innovative Approaches to Prevent and Treat Postpartum Hemorrhage in Low and Middle Income Countries (PPH) remains the l...
11/25/2024

Innovative Approaches to Prevent and Treat Postpartum Hemorrhage in Low and Middle Income Countries

(PPH) remains the leading cause of globally, with low- and middle-income countries ( ) bearing the greatest burden. A special research collection highlights the use of heat-stable carbetocin ( ) and tranexamic acid ( ) as promising solutions for PPH prevention and treatment in LMICs. Studies conducted across nine countries involving over 126,000 women demonstrate these interventions’ safety, feasibility, and potential for scaling in resource-limited settings.

👉 Discover more about innovative solutions transforming maternal health in LMICs. Read the full research collection here:

https://mchandaids.org/special-collection-implementation-research-evidence-for-prevention-and-treatment-of-postpartum-hemorrhage-in-high-burden-low-and-middle-income-countries/

coverage among -exposed and HIV-infected children in India varies significantly, influenced by location, socioeconomi...
11/17/2024

coverage among -exposed and HIV-infected children in India varies significantly, influenced by location, socioeconomic status, and parental education. Urban children generally have better access, while rural children face more barriers. The study highlights the need for focused strategies to address these disparities and improve rates in affected groups.

https://mchandaids.org/immunization-status-immunization-coverage-and-factors-associated-with-immunization-service-utilization-among-hiv-exposed-and-hiv-infected-children-in-india//

Heat-stable and tranexamic acid have shown promise in preventing and treating (PPH) in low- and middle-income countr...
10/25/2024

Heat-stable and tranexamic acid have shown promise in preventing and treating (PPH) in low- and middle-income countries. However, challenges include limited access, training, and policy support. Implementation research highlights their feasibility and safety, emphasizing the need for system improvements to expand their use effectively.

https://mchandaids.org/feasibility-acceptability-and-appropriate-use-of-novel-and-lesser-used-medicines-for-prevention-and-treatment-of-postpartum-hemorrhage-evidence-from-implementation-research/

Research on (PPH) in low and middle income countries explores heat-stable and acid as promising interventions for ...
10/20/2024

Research on (PPH) in low and middle income countries explores heat-stable and acid as promising interventions for PPH prevention and treatment. The findings from nine countries underscore the feasibility of these solutions in resource-constrained settings, addressing rates and supporting global health goals. The research contributes to improving PPH outcomes in alignment with Sustainable Development Goal 3.

https://mchandaids.org/special-collection-implementation-research-evidence-for-prevention-and-treatment-of-postpartum-hemorrhage-in-high-burden-low-and-middle-income-countries/

Involving in preventing mother-to-child transmission improves intervention outcomes. Male support, including adheren...
10/13/2024

Involving in preventing mother-to-child transmission improves intervention outcomes. Male support, including adherence to , condom use, and encouraging breastfeeding, enhances program effectiveness. However, challenges like cultural barriers and time limitations affect male participation. Their involvement is crucial for reducing HIV transmission to infants.

https://mchandaids.org/involvement-of-male-partners-in-sustaining-interventions-for-preventing-mother-to-child-transmission-of-hiv-among-women-with-hiv/

Address

6220 Rhode Island Avenue
Riverdale, MD
20737

Opening Hours

Monday 5:30pm - 7pm
Tuesday 5:30pm - 7pm
Wednesday 5:30pm - 7pm
Thursday 5:30pm - 7pm
Friday 5:30pm - 7pm

Telephone

+12404954944

Website

Alerts

Be the first to know and let us send you an email when International Journal of Maternal and Child Health & AIDS - IJMA posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to International Journal of Maternal and Child Health & AIDS - IJMA:

Shortcuts

Share

Category

Our Story

The International Journal of Maternal and Child Health and AIDS (IJMA) is the first open-access journal dedicated to publishing new research on global and national maternal and child health focused on the social determinants of health and disease as well as on the disparities in the burden of communicable and non-communicable diseases affecting infants, children, women, adults, and families across the world.

IJMA has become the journal of choice for major public health agencies including WHO, UNICEF, Management Sciences for Health and major universities and researchers around the world. We welcome high quality papers on MCH and HIV/AIDS issues. We welcome high-quality papers, opinion articles, and commentaries from scientists, researchers, and experts as well as those working with developing country populations.